- JulRecept - Julkort - JulSnaps - Snapsvisor - Skicka ett e-julkort - Rimlexikon - Julgodis - Julmönster - Sticka, brodera, virka - Luciasidan - Juklappstips -




Immunicum - English

The topline results of Immunicum's MERECA mRCC Phase II study were announced in a newsrelease Aug 30 2019. The results were partly very good with 11 % (5 of 45) of the patients getting complete tumor responses and  partly inconclusive so far regarding survival.


https://immunicum.se/investors/press-releases/press/?xml_id=1908171






loparn